Children with life-limiting conditions in paediatric intensive care units: a national cohort, data linkage study

Lorna K Fraser1, Roger Parslow2

  • 1Department of Health Sciences, University of York, York, UK.

Insights

Children with life-limiting conditions (LLCs) represent a significant portion of paediatric intensive care unit (PICU) admissions and deaths. These children face a substantially higher risk of mortality both in PICU and during the year following discharge.

Area of Science:

  • Pediatric Critical Care Medicine
  • Palliative Care
  • Health Services Research

Background:

  • Life-limiting conditions (LLCs) in children are complex and require specialized care.
  • Paediatric intensive care units (PICUs) manage critically ill children, including those with LLCs.
  • Understanding the outcomes for children with LLCs in PICU is crucial for service planning.

Purpose of the Study:

  • To quantify the number of children admitted to PICU with LLCs.
  • To determine the outcomes for these children during PICU stay and post-discharge.
  • To identify opportunities for improved care integration.

Main Methods:

  • A national cohort, data-linkage study was conducted using the Paediatric Intensive Care Audit Network dataset.
  • Children admitted to UK PICUs between 2004 and 2015 were identified.
  • International Classification of Diseases (ICD10) codes were used to identify children with LLCs; logistic regression and survival modeling analyzed outcomes.

Main Results:

  • Children with LLCs constituted 57.6% of PICU admissions and 72.9% of PICU deaths.
  • The mortality rate in PICU was higher for children with LLCs (5.4%) compared to those without (2.7%).
  • Children with LLCs were 75% more likely to die in PICU and 2.5 times more likely to die within a year post-discharge.

Conclusions:

  • Children with LLCs form a substantial part of the PICU population.
  • There is a need to integrate specialist paediatric palliative care with critical care.
  • Integration can improve choices regarding place of care for children with LLCs and their families.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
334
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
508
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
407